Non-Alcoholic Fatty Liver Disease: A Practical Guide

Overview

The sharp rise in cases of Non-alcoholic fatty liver disease is fast becoming one of the major concerns for hepatologists worldwide. This comprehensive clinical guide explains how to diagnose NAFLD and manage patients according to the best standards of care. Contributors from the world's leading institutions concentrate on patient care, drawing on their extensive experience.

Read More Show Less
... See more details below
Other sellers (Hardcover)
  • All (12) from $109.87   
  • New (11) from $109.87   
  • Used (1) from $147.27   

Overview

The sharp rise in cases of Non-alcoholic fatty liver disease is fast becoming one of the major concerns for hepatologists worldwide. This comprehensive clinical guide explains how to diagnose NAFLD and manage patients according to the best standards of care. Contributors from the world's leading institutions concentrate on patient care, drawing on their extensive experience.

Read More Show Less

Editorial Reviews

From the Publisher
“This book is useful for anyone who cares for patients with NAFLD — specialist or generalist. It provides both a general overview as well as a detailed look at disease mechanisms, clinical assessment, diagnosis, and treatment. It comes out in a timely fashion as diseases such as diabetes, obesity, metabolic syndrome, NAFLD, and NASH are on the rise.” (Doody’s, 24 January 2014)
Doody's Review Service
Reviewer: Heather Huang, MD (University of Wisconsin School of Medicine and Public Health)
Description: Wherever possible, this comprehensive overview and detailed look into nonalcoholic fatty liver disease (NAFLD) uses the latest evidence and scientific understanding of disease mechanisms.
Purpose: The purpose is to provide clinical guidance for the assessment, diagnosis, and treatment of patients with this disease. This book is needed, as the incidence of NAFLD has risen significantly over the past few decades.
Audience: According to the authors, the audience includes hepatologists and any health professionals who manage patients with NAFLD.
Features: This book provides a clear overview of the causative mechanisms of NAFLD. The pathophysiology is put into further context with several chapters that analyze NAFLD in relation to obesity, diabetes, high cholesterol, and liver cancer. In offering clinical guidance, the book addresses both the difficulties and realities of diagnosis and treatment. Finally, it covers the latest national and international guidelines, discusses the latest in clinical drug trials, and, in several chapters, explores the disease nationally and internationally. Throughout the book, key points are summarized and multiple-choice questions at the end of every chapter aid in self-assessment.
Assessment: This book is useful for anyone who cares for patients with NAFLD — specialist or generalist. It provides both a general overview as well as a detailed look at disease mechanisms, clinical assessment, diagnosis, and treatment. It comes out in a timely fashion as diseases such as diabetes, obesity, metabolic syndrome, NAFLD, and NASH are on the rise.
Read More Show Less

Product Details

  • ISBN-13: 9780470673171
  • Publisher: Wiley
  • Publication date: 4/22/2013
  • Edition number: 1
  • Pages: 324
  • Product dimensions: 6.80 (w) x 9.60 (h) x 1.20 (d)

Read an Excerpt

Click to read or download

Read More Show Less

Table of Contents

List of Contributors, vii

1 What is non-alcoholic fatty liver disease (NAFLD), and why is it important? 1
Geoffrey C. Farrell, Arthur J. McCullough, and Christopher P. Day

2 NAFLD in the community, 17
Leon A. Adams

3 Pathology of NAFLD, 27
Elizabeth M. Brunt and David E. Kleiner

4 The natural history of NAFLD, 37
Paul Angulo

5 Emerging concepts on the pathogenesis of non-alcoholic steatohepatitis (NASH), 46
Isabelle A. Leclercq

6 Diabetes and NAFLD: why is the connection important? 62
Elisabetta Bugianesi

7 NAFLD and cardiovascular risk factors: implications for vascular disease, 71
Giovanni Targher

8 A primary care perspective of fatty liver: diagnosis, management, prescribing, and when to refer, 84
Shivakumar Chitturi and Geoffrey C. Farrell

9 Imaging of NAFLD, 93
Takeshi Yokoo, An Tang, and Claude B. Sirlin

10 Non-invasive methods to determine the severity of NAFLD and NASH, 112
Vincent Wai-Sun Wong and Henry Lik-Yuen Chan

11 Fatigue, quality of life, and psychosocial issues for people with NAFLD, 122
Julia L. Newton and James Frith

12 Physical activity and cardiovascular fi tness in patients with NAFLD: clinical importance and therapeutic implications, 132
Ingrid J. Hickman, Graeme A. Macdonald, and Nuala M. Byrne

13 NAFLD, obesity, and bariatric surgery, 149
Philippe Mathurin

14 Genetic predisposition to NAFLD and NASH: implications for pathogenesis, diagnosis, prevention, and management, 157
Quentin M. Anstee, Ann K. Daly, and Christopher P. Day

15 NAFLD in children, 171
Ariel E. Feldstein

16 The pointy end of the NAFLD iceberg: cirrhosis, portal hypertension, and liver failure, 182
Jonathon W. Schwake, Dawn M. Torres, and Stephen A. Harrison

17 Non-alcoholic fatty liver disease, hepatocellular cancer, and other cancers, 192
Janine Graham and Helen L. Reeves

18 NAFLD in Chinese and South Asian people, 206
Jia-Horng Kao, Deepak Amarapurkar, and Jian-Gao Fan

19 Non-alcoholic fatty liver disease in Japan, 217
Takeshi Okanoue, Kohichiroh Yasui, and Yoshito Itoh

20 Non-alcoholic fatty liver disease in South America and Hispanic people, 228
Helma Pinchemel Cotrim and Carla Daltro

21 Alcohol in non-alcoholic fatty liver disease: an oxymoron or a new standard of care?, 234
Achuthan Sourianarayanane, Srinivasan Dasarathy, and Arthur J. McCullough

22 Dietary factors in the pathogenesis and care of patients with fatty liver disease, 248
Giulio Marchesini, Rebecca Marzocchi, Anna S. Sasdelli, Cristiana Andruccioli, and Silvia Di Domizio

23 Metabolic factors and steatosis in patients with hepatitis B and C, 260
Francesco Negro

24 Drug therapy for NASH: insulin-sensitizing agents (metformin and thiazolidinediones), 271
Mohammad S. Siddiqui and Arun J. Sanyal

25 Hepatoprotectants against fatty liver disease: antioxidants, ursodeoxycholic acid, and herbal medicines, 284
Anne Catherine Bürgi and Jean-François Dufour

26 Lipid modifiers and NASH: statins, ezetimibe, fibrates, and other agents, 293
Giovanni Musso, Federica Molinaro, Elena Paschetta, Roberto Gambino, and Maurizio Cassader

Index, 308

Color plate section facing p86

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)